Human Germline Modification Is Coming

Introduction Inside a decade, the U.S. Food & Drug Administration (FDA) will approve clinical trials for the genomic modification of a viable human embryo in order to prevent disease. That seems a real possibility in light of significant developments in policy and research this year. While such trials are currently barred in the United States by federal law, the prospect of future trials gained key support from the National Academies of Sciences, Engineering, and Medicine Continue Reading →

STLR Link Roundup – October 27, 2017

Listeria-Based Recall In US and Canada California-based vegetable supplier Mann Packing has issued a voluntary recall of certain “minimally processed” vegetable and vegetable-containing products from its customers across the US and Canada. According to the company announcement posted on the FDA’s website, the distributor made the decision after the Canadian Food Inspection Agency found “a single positive result” of Listeria monocytogenes in one of their products. All products covered in the recall carried “best if used by” Continue Reading →